Saussure Pharma SRL
Saussure Pharma reported total assets of 509,667 € at the end of the 2025 financial year (annual accounts filed with the NBB on 08 Jul 2026).
The score of Saussure Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +107 % Total assets -4 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Saussure Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
Saussure Pharma's financial analysis
- Solvency10.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Saussure Pharma
Saussure Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0740.545.114
- VAT number
- BE0740545114
- Peppol
- Registered · 0208:0740545114 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Dec 2019
- Registered office
- 5570 Beauraing
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Saussure Pharma (SRL) has been based in Beauraing since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,410 € and equity of 54,488 €; its revenue is not published. Its solvency stands at 10.7%, below the median of its sector (41.5%).
Companies similar to Saussure Pharma
Companies in the same business, of comparable size and area, outside its group.
- Wolfs Pharma Retail sale of pharmaceutical products Liège · balance sheet 509,540 €
- Apotheek Bresseleers-Van der Cruyce Retail sale of pharmaceutical products Buggenhout · balance sheet 509,818 €
- Pharmacie Huart Retail sale of pharmaceutical products Durbuy · balance sheet 509,185 €
- Onco-HEM Retail sale of pharmaceutical products Binche · balance sheet 511,591 €
- Apoteek Diependale Retail sale of pharmaceutical products Oudenaarde · balance sheet 504,088 €
- Almapharma Retail sale of pharmaceutical products De Panne · balance sheet 515,565 €
- Curepharma Retail sale of pharmaceutical products Antwerp · balance sheet 516,103 €
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
Frequently asked questions about Saussure Pharma
What is the revenue of Saussure Pharma?
Saussure Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Saussure Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0740545114 for Saussure Pharma, if the company is VAT-registered. Its company number (CBE) is 0740.545.114.
Where is the registered office of Saussure Pharma?
According to the CBE register, the registered office of Saussure Pharma is in 5570 Beauraing.
What is the equity of Saussure Pharma?
At the close of the 2025 financial year, the equity of Saussure Pharma amounts to 54,488 €, a solvency of 10.7% of total assets.
Who manages Saussure Pharma?
The register lists 1 active mandates at Saussure Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Saussure Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →